You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 2, February 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  LETTERS TO THE EDITOR
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ataxia-Telangiectasia

CAPT Rayburn R. Skoglund, MC
USN

Department of Pediatrics Clinical Investigation Department Naval Hospital San Diego, CA 92134

Arch Neurol. 1984;41(2):137.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—There is no treatment for the movement disorder associated with ataxia-telangiectasia. In the examination of a 6-year-old boy with this disorder, a debilitating motor disturbance was apparent. Test results for intellectual and behavior functions were normal.

Report of a Case.

—A school referral issued a complaint that ambulation by the patient was no longer safe, handwriting was illegible, and speech was difficult to understand. Drooling complicated his social acceptance.

Motor examination was characterized by findings of moderate hypotonia, brisk symmetric reflexes, and bilateral extensor plantar responses. Appendicular, trunkal atactic, and choreoathetoid movements complicated ambulation. The boy needed to touch the wall for stability.

Reports that methylphenidate hydrochloride administration improved motor performance in familial choreoathetosis and children with cerebral dysfunction prompted a trial of this medication in this patient.1-3

A 10-mg morning and noon dosage of methylphenidate was initially selected. The result was dramatic. Safe ambulation was . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.